Immunomodulation of gut-associated lymphoid tissue: current perspectives. (Articolo in rivista)

Type
Label
  • Immunomodulation of gut-associated lymphoid tissue: current perspectives. (Articolo in rivista) (literal)
Anno
  • 2009-01-01T00:00:00+01:00 (literal)
Alternative label
  • Luongo D; D'Arienzo R; Bergamo P; Maurano F; Rossi M. (2009)
    Immunomodulation of gut-associated lymphoid tissue: current perspectives.
    in International reviews of immunology (Print)
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Luongo D; D'Arienzo R; Bergamo P; Maurano F; Rossi M. (literal)
Pagina inizio
  • 446 (literal)
Pagina fine
  • 464 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 28 (literal)
Rivista
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo
  • 6 (literal)
Note
  • ISI Web of Science (WOS) (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • Istituto di Scienze dell'Alimentazione (literal)
Titolo
  • Immunomodulation of gut-associated lymphoid tissue: current perspectives. (literal)
Abstract
  • The gut-associated lymphoid tissue is deputed both to protect from infectious diseases and to evoke immune tolerance. Efficient responses need mucosal adjuvants: starting from cholera toxin, new variants of cholera toxin were developed depleted of toxicity. In addition, lipid colloidal particles, bacterial DNA, and probiotics have been experimented. Tolerance is currently induced by means of the B subunit of cholera toxin, whereas new strategies encompass the use of probiotics, expansion of regulatory T cells and blocking of paracellular entry of antigens. Finally, we report different approaches developed for celiac disease, an immune-mediated disease whose triggering antigen is known. (literal)
Prodotto di
Autore CNR

Incoming links:


Prodotto
Autore CNR di
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
data.CNR.it